CRISPR Gene Detection and Diagnostic Markets by Research, Clinical Lab, Consumer, Public Service & Other with Executive and Consultant Guides. 2023 to 2027

Table of Contents

1 Market Guides
1.1 CRISPR Gene Detection Markets - Strategic Situation Analysis  
1.2 Guide for Executives, Marketing, Sales and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors

2 Introduction and Market Definition  
2.1 Methodology  
2.1.1 Methodology  
2.1.2 Sources  
2.1.3 Authors  
2.2 CRISPR Gene Detection Definition In This Report  
2.2.1 Research  
2.2.2 Clinical Laboratory  
2.2.3 Consumer Diagnostics  
2.2.4 Public Service  
2.2.5 Other  
2.3 CRISPR  
2.3.1 What is CRISPR?  
2.3.2 What is Gene Detection?  
2.3.3 The CRISPR Family  
2.3.4 Sensitivity of CRISPR  
2.4 Chromosomes, Genes and Epigenetics  
2.4.1 Chromosomes  
2.4.2 Genes  
2.4.3 Epigenetics  
2.5 Market Definition  
2.5.1 Revenue Market Size  
2.6 Perspective: Healthcare and the IVD Industry  
2.6.1 Global Healthcare Spending  
2.6.2 Spending on Diagnostics  
2.6.3 Important Role of Insurance for Diagnostics  

3 Market Overview  
3.1 Players in a Dynamic Market. 
3.1.1 Academic Research Lab  
3.1.2 Diagnostic Test Developer  
3.1.3 Instrumentation Supplier  
3.1.4 Chemical/Reagent Supplier  
3.1.5 Pathology Supplier  
3.1.6 Independent Clinical Laboratory  
3.1.7 Public National/regional Laboratory  
3.1.8 Hospital Laboratory  
3.1.9 Physicians Office Lab (POLS)  
3.1.10 Audit Body  
3.1.11 Certification Body. 
3.2 Genetic Material Detection Markets, Examples and Discussion  
3.2.1 Research Markets  
3.2.2 Clinical Laboratories - Accuracy, Cost and Speed  
3.2.2.1 Multiplexing in the Lab and at the Point of Care  
3.2.3 Consumer Diagnostics  
3.2.3.1 The CRISPR Consumer  
3.2.3.2 Why Consumers Like Multiplexing 
3.2.4 Public Service Markets  
3.2.4.1 Public Health  
3.2.4.2 Public Security  
3.2.4.3 Environmental Monitoring  
3.2.5 AgriBio and Other Markets  
3.2.5.1 AgriBio  

4 Market Trends  
4.1 Factors Driving Growth  
4.1.1 Cost, Accuracy and Speed  
4.1.2 The Economies of Multiplexing with Nucleic Acids  
4.1.3 The New Agriculture  
4.1.4 Pandemics and Pathogens  
4.1.5 Health and Self - A Sea Change in Healthcare  
4.2 Factors Limiting Growth  
4.2.1 Ubiquitous PCR  
4.2.2 The Shrinking Cost of All Things Genetic  
4.2.3 Wellness has a downside  
4.2.4 The Limits of Detection  

5 CRISPR Recent Developments  
5.1 Recent Developments - Importance and How to Use This Section  
5.1.1 Importance of These Developments  
5.1.2 How to Use This Section  
5.2 CRISPR Enzyme Discovery Opens Diagnostic Applications  
5.3 Sherlock Biosciences Adds Ambient Amplification to Diagnostic Toolkit  
5.4 Rice University Adapts CRISPR Enzyme to Create Ultra-Sensitive Test 
5.5 CRISPR-Based Tb Test Shows High Sensitivity  
5.6 Princeton Group Develops Cas13 Assay for Point-of-Care Use  
5.7 Proof Dx Plans Infectious Disease, Oncology Tests for CRISPR-Based POC System  
5.8 Sherlock Biosciences Raises $80M  
5.9 Broad Institute Considers CRISPR Respiratory Panels to Replace PCR  
5.10 Medix Biochemica Acquires MyPols Biotec  
5.11 Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets EUA  
5.12 UCSD Developing At-Home Covid Test Leveraging CRISPR  
5.13 Genome Diagnostics Makes €1M Investment in CRISPR Dx Startup Scope Biosciences
5.14 CRISPR SARS-CoV-2 Test Could be used for Asymptomatic Screening  
5.15 Mammoth Biosciences, Agilent to Comarket CRISPR-Based SARS-CoV-2 Test  
5.16 Pandemic Accelerates Development of CRISPR Diagnostics  
5.17 COVID Assays Use CRISPR and Smartphones  
5.18 ERS Genomics Licenses CRISPR Patents to Vivlion   
5.19 Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test   
5.20 ERS Genomics, FASMAC to Commercialize CRISPR-Cas9   
5.21 The Nobel Prize in Chemistry 2020 - CRISPR Wins   
5.22 Caspr Biotech Developing COVID Dx   

6 Key Companies   
6.1 10x Genomics, Inc.   
6.2 Agilent/Dako   
6.3 Axxam   
6.4 Beckman Coulter Diagnostics   
6.5 Becton, Dickinson and Company   
6.6 Binx Health   
6.7 bioMérieux Diagnostics  
6.8 Bio-Rad Laboratories, Inc.   
6.9 Caspr Biotech   
6.10 ERS Genomics  
6.11 Illumina  
6.12 Janssen Diagnostics   
6.13 Locus Biosciences   
6.14 Mammoth Biosciences   
6.15 Myllia Biotechnology   
6.16 Proof Diagnostics   
6.17 Roche Molecular Diagnostics   
6.18 Sherlock Biosciences   
6.19 Thermo Fisher Scientific Inc.   
6.20 Vivlion   

7 The Global Market for CRISPR Gene Detection and Diagnostics   
7.1 Global Market Overview by Country   
7.1.1 Table - Global Market by Country   
7.1.2 Chart - Global Market by Country   
7.2 Global Market by Application - Overview   
7.2.1 Table - Global Market by Application   
7.2.2 Chart - Global Market by Application - Base/Final Year Comparison   
7.2.3 Chart - Global Market by Application - Base Year   
7.2.4 Chart - Global Market by Application - Final Year   
7.2.5 Chart - Global Market by Application - Share by Year   
7.2.6 Chart - Global Market by Application - Segment Growth   
7.3 Global Market Organism - Overview   
7.3.1 Table - Global Market by Organism   
7.3.2 Chart - Global Market by Organism - Base/Final Year Comparison   
7.3.3 Chart - Global Market by Organism - Base Year   
7.3.4 Chart - Global Market by Organism - Final Year   
7.3.5 Chart - Global Market by Organism - Share by Year  
7.3.6 Chart - Global Market by Organism - Segment Growth  

8 Global CRISPR Gene Detection and Diagnostics Markets - By Application
8.1 Research   
8.1.1 Table Research - by Country   
8.1.2 Chart - Research Growth   
8.2 Clinical Laboratory   
8.2.1 Table Clinical Laboratory - by Country   
8.2.2 Chart - Clinical Laboratory Growth   
8.3 Clinical Consumer   
8.3.1 Table Clinical Consumer - by Country   
8.3.2 Chart - Clinical Consumer Growth   
8.4 Public Service   
8.4.1 Table Public Service - by Country   
8.4.2 Chart - Public Service Growth   
8.5 Agriculture/Other   
8.5.1 Table Agriculture/Other - by Country   
8.5.2 Chart - Agriculture/Other Growth   

9 Global CRISPR Gene Detection and Diagnostics Markets - by Organism   
9.1 Human   
9.1.1 Table Human - by Country   
9.1.2 Chart - Human Growth   
9.2 Pathogen   
9.2.1 Table Pathogen - by Country   
9.2.2 Chart - Pathogen Growth   
9.3 Other Organism   
9.3.1 Table Other Organism - by Country   
9.3.2 Chart - Other Organism Growth  

10 Appendices   
10.1 United States Medicare System: laboratory Fees Schedule   
10.2 The Most Used IVD Assays   
10.3 The Highest Grossing Assays   
10.4 The Whole Genome Sequence of SARS-CoV-2  
10.5 Global Listing of Sequencing Establishments - Location & Contacts  

Table of Tables
Table 1  The Base Pairs  
Table 2 CRISPR Assays Types & Times  
Table 3 CRISPR Assays Readouts & Application  
Table 4 The Base Pairs 
Table 5  Market Players by Type  
Table 6 The Different Markets for Genetic Detection  
Table 7  Other Uses for CRISPR Gene Detection  
Table 8 The Factors Driving Growth  
Table 9 Factors Limiting Growth  
Table 10 - Global Market by Region   
Table 11 Global Market by Application
Table 12 Global Market by Organism   
Table 13 Research by Country   
Table 14  Clinical Laboratory by Country   
Table 15 Clinical Consumer by Country   
Table 16 Public Service by Country   
Table 17 Agriculture/Other by Country   
Table 18 Human by Country   
Table 19  Pathogen by Country   
Table 20 Other Organisms by Country   
Table 21  Clinical Lab Fee Schedule   
Table 22  The Most Common Assays   
Table 23 Largest Revenue Assays   
Table 24 List of Global Sequencing Locations  

Table of Figures
Figure 1 DNA Strands and Chromosomes  
Figure 2 Karyogram of Human Chromosomes  
Figure 3 Size of Various Genomes  
Figure 4 Global Healthcare Spending  
Figure 5 The Lab Test Pie  
Figure 6 The Road to Diagnostics  
Figure 7 - Cost To Sequence a Human Genome  
Figure 8 Base Year Country Market Share Chart   
Figure 9 Global Market by Application - Base vs. Final Year   
Figure 10 Global Market by Application Base Year   
Figure 11 Global Market by Application Final Year   
Figure 12 Application Type Share by Year   
Figure 13 by Application Segment Growth   
Figure 14 by Organism - Base vs. Final Year   
Figure 15 by Organism Market Base Year   
Figure 16 by Organism Market Final Year   
Figure 17 by Organism Share by Year   
Figure 18 by Organism Segment Growth   
Figure 19 Research Growth   
Figure 20 Clinical Laboratory Growth   
Figure 21 Clinical Consumer Growth  
Figure 22 Public Service Growth   
Figure 23 Agriculture/Other Growth   
Figure 24 Human Growth  
Figure 25 Pathogen Growth   
Figure 26 Other Organism Growth

Samples

Companies Mentioned

• 10x Genomics, Inc.   
• Agilent/Dako   
• Axxam   
• Beckman Coulter Diagnostics   
• Becton, Dickinson and Company   
• Binx Health   
• bioMérieux Diagnostics  
• Bio-Rad Laboratories, Inc.   
• Caspr Biotech   
• ERS Genomics  
• Illumina  
• Janssen Diagnostics   
• Locus Biosciences   
• Mammoth Biosciences   
• Myllia Biotechnology   
• Proof Diagnostics   
• Roche Molecular Diagnostics   
• Sherlock Biosciences   
• Thermo Fisher Scientific Inc.   
• Vivlion